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Summary Thirty-five cases of Hodgkin's disease (HD) were analysed for the presence of Epstein-Barr virus
(EBV) and human herpesvirus-6 (HHV-6) DNA. EBV genomes were detected in 11/35 cases while none of the
cases was positive for HHV-6. Ten of the EBV-positive cases were subsequently analysed using a probe for the
terminal region of the virus; the results suggested that the EBV-infected cells were clonally expanded. EBV
subtype specific DNA amplification was used to demonstrate that EBV subtype A, and not subtype B was
present in the EBV-positive cases. The age distribution of the EBV-positive cases indicated a statistically
significant trend for an increase in positivity with increasing age. This is the first indication that EBV is
significantly associated with any subset of HD patients.
The aetiology of Hodgkin's disease (HD) is at present un-
known. A bimodal age incidence has been described for the
disease with a peak occurring in young adults, aged 15-34
years, and a second peak occurring in older persons (Mac-
Mahon, 1966). A more recent study from the UK failed to
detect the second age peak although the age incidence varied
for the different subtypes of HD (McKinney et al., 1989).
The nodular sclerosing (NS) subtype of HD showed a uni-
modal curve with a peak between the ages of 15-34 years. In
contrast the mixed cellularity (MC) subtype showed an in-
crease in incidence with increasing age, a pattern similar to
that seen in other lymphomas. These features suggest that
HD is an heterogeneous entity and that different aetiologies
may be involved in different age-groups or disease subtypes.
Epidemiological data have indicated that higher social
class and small sibship size are associated with an increased
risk of HD in younger age groups (Gutensohn, 1982). These
studies support the hypothesis that HD in younger persons
may arise as an unusual and late host response to a common
infectious agent. Alexander et al. (1989) found evidence of
local spatial clustering of young cases of HD, particularly of
the nodular sclerosing subtype supporting the hypothesis that
case to case transmission of an infectious agent is involved.
Serological studies have identified members of the human
herpesvirus family as possible candidate infectious agents.
Many studies have shown an association between elevated
antibody titres to Epstein-Barr virus (EBV) antigens and HD
(Henle & Henle, 1973; Hesse et al., 1977; Evans & Guten-
sohn, 1984). Increased antibody levels are present before the
diagnosis of disease (Mueller et al., 1989) suggesting that
these findings are not solely a consequence of immunosup-
pressive therapy. In addition there appears to be an increased
risk of HD following infectious mononucleosis (Munoz et al.,
1978; Bernard et al., 1987). Although early studies failed to
detect EBV genomes in tumour material from HD patients,
recently EBV genomes have been detected in 17-41% of
cases using Southern hybridisation (Weiss et al., 1987, 1989;
Anagnostopoulos et al., 1989; Boiocchi et al., 1989; Staal et
al., 1989).
Evidence linking other human herpesviruses to HD is less
strong though recent studies have shown elevated antibody
titres to human herpesvirus type-6 (HHV-6) in HD patients
(Ablashi et al., 1988; Biberfeld et al., 1988; Clark et al.,
1990).
We have analysed 35 non-selected cases of HD for the
presence of EBV and HHV-6 genomes. In those cases found
to be positive for EBV DNA the clonality of the EBV-
infected cells was assessed. The results were analysed for age
and HD-subtype distribution.
Two strains of EBV have been described which differ in
their biological properties and can be distinguished immuno-
logically and molecularly on the basis of differences in the
EBNA 2 and EBNA 3 genes (Zimber et al., 1986; Young et
al., 1987; Sample et al., 1990). EBV type B which yields
transformed cell lines readily than EBV type A in vitro
(Rickinson et al., 1987), has been considered rare in Western
populations, though recent data suggest that type B virus
may be widely distributed in the West (Sixbey et al., 1989).
In order to determine whether a particular viral strain is
associated with HD, we investigated the type of EBV present
in our positive cases.
The analysis ofT-cell receptor (TCR) and immunoglobulin
(Ig) gene rearrangement has been used to study the clonality
and lineage of the putative malignant cells in HD, the Reed
Sternberg cells and their mononuclear counterparts (HRS
cells). The results of such studies have been conflicting, in
particular there has been significant variation in the number
of cases in which TCRP chain (TCRJ) gene rearrangement
has been detected (Herbst et al., 1989; Griesser et al., 1987;
Raghavachar et al., 1988; O'Connor et al., 1987). We have
examined the relationship between the presence of Ig and
TCRP gene rearrangement and the detection of EBV in our
material, and correlated these findings with the numbers of
HRS cells present in the samples.
Materials and methods
Clinical cases
Lymph node or spleen samples from 35 non-selected cases of
HD and 14 cases of non-Hodgkin's lymphoma (NHL) occur-
ring in patients over 60 years old were obtained from three
referral centres. Following histological review HD cases were
classified according to the Rye classification (Lukes et al.,
1986). HRS cells were identified on the basis of morphology
in haematoxylin and eosin-stained sections and their fre-
quency as a percentage was estimated. Seventeen HD cases
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were included in a previous analysis of lymphoma material
for HHV-6 DNA (Jarrett et al., 1988). The genotypic ana-
lysis of cases 16-24, 26 and 27 has been reported previously
(Gledhill et al., 1990).
Molecular analysis
DNA was extracted from tissue biopsies as previously des-
cribed (Jarrett et al., 1988) and digested with appropriate
restriction enzymes according to the manufacturers recom-
mendations. Following digestion samples were run on 0.6-
0.8% agarose gels for 20 h at 1 V cm-', transferred to
Hybond-N membrane (Amersham International plc) and
hybridised with 32p labelled probes. Filters were washed
extensively at 650C in 0.5 x SSC, 0.1% SDS (1 x SSC is
0.15 M NaCl, 0.015 M sodium citrate pH 7.0) before auto-
radiography.
The intensity of rearranged bands following autoradio-
graphy using preflashed X-ray film, was measured on a
Molecular Dynamics densitometer and analysed using Image-
Quant software. The use of this method to estimate the
proportion of cells with a clonal gene rearrangement was
validated using reconstitution experiments with 2-100% of
sample DNA derived from cells with two rearranged Ig
heavy chain (IgH) genes (data not shown).
The IgH gene probe, pHj, was a 3.3 kb EcoRI-HindIII
fragment containing 2.2 kb of the 3' JH sequences (Erikson et
al., 1982). Two probes were used to analyse Ig light chain
(IgL) gene rearrangement; the K light chain probe, Cic, a
2.5 kb fragment containing the constant region (Rabbitts et
al., 1984) and a probe for the K deleting element, icde, which
detects K gene loss (Siminovitch et al., 1985). The TCRP gene
probe was an XhoI-EcoRI fragment of C91P containing con-
stant region sequences only (Gledhill et al., 1990).
The probe for HHV-6 was pZH14, a 9 kb fragment of the
virus which contains sequences that do not hybridise with
other known human herpesviruses (Josephs et al., 1986). Two
EBV probes were used, BamH1-W and EcoRI-D (Arrand et
al., 1981). The BamHI-W probe for the internal repeat ele-
ment contains sequences reiterated 7-12 times in the EBV
genome and was used as a sensitive indicator for the presence
of EBV. The EcoRI-D terminal fragment probe was used to
assess the clonality of EBV positive samples (Figure 3).
The results of these experiments were analysed with respect
to the histological subtype of HD and the age of the cases.
Three age groups of HD patients can be distinguished
epidemiologically; the age ranges of these groups are 0-14
years, 15-34 years and 50 years and over (MacMahon,
1966). Since there were only two cases aged <15 years in
our study we included these in a group aged <35 years.
Cases aged 35-49 years, which are thought to represent an
overlap between the young adult and older groups, were
included as a separate category.
DNA amplification
Specific amplification of Type A or Type B EBV was
achieved using primers derived from the EBNA 2 gene
sequence (Sample et al., 1990). A common 5' primer,
AGGGATGCCTGGACACAAGA, a type A specific 3' primer,
TTGTGACAGAGGTGACAAAA, and a type B specific 3'
primer, TTGAAGAGTATGTCCTAAGG, were used to
amplify products of 249 bp and 300 bp respectively.
Two jg of high molecular weight DNA and 1 gM primers
were included in a reaction mixture containing 1.5 mM
MgCl2, 50 mM KCI, 10 mM Tris pH 8.2, 200 tm nucleotides
and 3 U Tsp type 2 (Cambio). Amplification was performed
in a programmable heat block (Perkin Elmer-Cetus instru-
ments). Samples were denatured by heating them from 700 to
95°C over 1 min, cooled to 55°C over 2 min to anneal the
primers, heated to 70° in 1 min and incubated at that tem-
perature for 0.5 min.
Reaction products were visualised on ethidium bromide-
staining polyacrylamide gels, and hybridised to type-specific
oligonucleotide probes: EBV Type A; TCCAGCCACATG
TCCCCCCTCTACGCCCGACA, EBV Type B; AACGTCA
ACCTGTCCACAACCCTCGCCAGGAG.
Results
The age, sex, histopathological diagnoses and results of
molecular analyses for the 35 HD cases are given in Table I.
The cases analysed included 24 cases of NSHD, six cases
of MCHD, two cases of lymphocyte predominant HD
(LPHD) and one case of lymphocyte depleted HD (LDHD).
In two additional cases no consensus was reached as to the
correct diagnosis following histological review. Case 3 was
referred to us as NSHD but was considered to be classi-
ficable as MCHD by one of us (D.H.W.). For case 9, listed
in Table I as NSHD, the possibility of sclerosing mediastinal
B-cell lymphoma was raised, but NSHD was not excluded as
a differential diagnosis. As case 9 was originally referred to
us with a diagnosis of NSHD we have included it in the
study.
EBV DNA sequences were detected in 11/35 HD samples
using the BamHI-W fragment as probe (Figure 1). Ten of the
11 samples were subsequently hybridised to the probe for the
terminal fragment, EcoRI-D. There was insufficient DNA to
analyse sample 27. Hybridisation of this probe to BamHI-
EcoRI double digested DNA detected an invariant band of
6.5 kb representing the overlapping regions of the BamHI-A
and EcoRI-D fragments and a single band of varying size
representing the terminal fragment (Figure 2 and 3). The
data show that the EBV-infected cells, in each case, contain
EBV episomes with the same number of terminal repeats.
This is consistent with the presence of a clonally expanded
population of EBV-infected cells (Raab-Traub & Flynn,
1986).
The ages and histological subtypes of the EBV-positive
and negative cases were compared (Figure 4). HDNS was
compared to all other subtypes because of the small numbers
of the LDHD and LPHD subtypes analysed. The compari-
son showed an excess of EBV-positive cases in the 'all other
subtypes' compared to the NSHD category, but this did not
attain statistical significance. Ifcases 3 and 9, for which there
was not unanimous agreement on classification, are excluded
from the analysis P = .08 using a two tailed Fisher's exact
test for difference in proportions. If both cases 3 and 9 are
considered to be NSHD then P = 0.16.
EBV positivity in the three age groups, <35 years, 35-49
years and >49 years was analysed. In the younger age
group, which made up the majority of the cases, only three
out of 23 cases were EBV-positive while in the older age
group six out of seven cases were EBV-positive. The trend
for an increase in the number of EBV-positive cases with
increasing age is statistically significant (Armitage test for
trend, X 2= 8.56, P<0.01). The two cases aged <15 years
who were included in the group aged <35 years were both
EBV positive.
In order to study further the significance of these findings
we analysed 14 NHL samples from patients over 60 years old
for the presence of EBV. EBV DNA sequences were detected
in one out of 14 NHL samples (data not shown). Hybridisa-
tion to the EBV probe in the positive sample, an high grade
NHL, was detected only after prolonged exposure of the
autoradiograph and was weak compared to the hybridisation
observed in the HD samples. It was not possible to assess the
clonality of the EBV infected cells in this sample because of
the lower sensitivity of the EcoRI-D probe compared to the
BamHI-W probe.
EBV type A was detected in all of the eight EBV-positive
cases analysed by DNA amplification using EBV type-specific
primers (Figure 5). No DNA was available for the analysis of
samples 1, 14 and 27. No amplification was detected in any
of the eight samples when EBV type B specific primers were
used.
HHV-6 DNA sequences were not detected in any of the 35
cases include in this study or the 12 additional cases exam-
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Table I Age, sex, diagnoses and results ofmolecular analyses for the 35 cases
Gene rearrangements
No. Age/sex HD subtype % HRS cells TCR-P IgH(%*) IgL HHV-6 EBV
1 36/M LP - G G G - +
2 22/M NS + G G G - -
3 21/M NS/MC + G G G - +
4 20/M MC ND G G G - -
5 24/M NS ND G G G - -
6 19/M NS + G G G - -
7 31/F NS +++ G R(+++) RK - -
8 48/F MC + G G G - -
9 50/F NS/BNHL + + + G R (+ + +) RK - +
10 19/M LD +++ G R(+++) Ric - +
11 67/M NS +++ G R(+++) Ric - -
12 24/M NS + + G G G - -
13 19/M NS + + G G G - -
14 77/M MC + G R (+ +) G - -
15 26/M NS + + G G N - +
16 25/M MC + + + G G G - -
17 43/M NS + + + G G G - -
18 66/M NS +++ G R(+++) Ricde -
19t 23/M NS - G R (+ + +) RKcde - +
20 28/F NS + G G G - -
21 31/M NS + G G G - -
22 80/M MC +++ G R(+++) RK - -
23 14/M MC + G G G - +
24 68/F NS + + + G G G - +
25 13/M NS + + G G G - +
26 35/M NS + + G G G - +
27 69/M NS - G G G - +
28 19/M NS + + + G G G - -
29 17/M LP - G G G - +
30 32/M NS + + G G G - -
31 42/M NS + + G G G - -
32 25/F NS +++ G R(+++) G - -
33 26/M NS + + + G G G - -
34 21/F NS + + + G G G - -
35 15/NK NS ND G G G - -
The differential diagnosis are shown for cases 3 and 9. HRS, Reed-Stemnberg and mononuclear
counterpart; BNHL, B-ell NHL; G, germline; R, rearranged; ND, not done; NK, not known; x,
rearrangementdetected using Igc probe;Kcde, rearrangement detected usingxdeprobe; *, thepercentage of
cellscontainingtheIgHgenerearrangement asestimatedbydensitometry; + + +, >8%; + +, 3-8%; +,
<3%; -, lessthanoneHRScellperhigh-power field; t, theresults shownare fromtheanalysisofalymph
nodebiopsywiththehistologicalappearance ofareactivenode(seetext). Thiscasewaspreviouslydescribed
asMCHD(Gledhilletal., 1990), butafterreviewingthespleenhistologyNSHDwasconsidered tobeamore
appropriate diagnosis.
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Figure 1 Southern blot analysis of representative positive HD
samples using the BamHI-W probe. Lane numbers correspond to
case numbers; P, placenta (negative control; B, the EBV-infected
cell line B95-8 (positive control). A positive result is indicated by
the presence of a hybridising fragment at approximately 3 kb.
Additional bands visualised in lanes 18 and B represent the
fragments flanking the BamHI-W repeat sequence.
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Figure 2 Southern blot analysis of representative EBV genome
positive HD samples using the EcoRI-D terminal fragment probe.
Lane numbers correspond to case numbers; P, placenta (negative
control); B, the EBV-infected cell line B95-8 (positive control). In
EcoRI-BamHI digested samples containing EBV DNA an invar-
iant band of 6.5 kb is seen (only faintly visible in sample 24). In
the HD samples a band of variable size (arrowed) which repre-
sents the fused terminal fragements is also seen. The ladder of
smaller fragments present in the positive control is due to the
presence of linear EBV genomes and episomal forms that contain
variable numbers of terminal repeats (see Figure 3, Raab-Traub
& Flynn, 1986).
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cell population made up more than 8°/
The numbers of HRS cells in histolog
samples were also estimated to be
population. Sample 14 was estimated
HRS cells while densitometry of the rearrangement indicated
R B that 3-8% of cells contained that clonal rearrangement. In
_l lul sample 19 Ig gene rearrangement was detected when no HRS
cells were seen in the lymph node biopsy examined histo-
logically. Possible explanations for this finding have been
discussed elsewhere (Banks et al., 1991). Six samples in which
HRS cell numbers were greater than 8% had germline IgH
genes.
A comparison between the detection of rearranged IgH
V. R, genes and EBV DNA sequences in the HD samples showed
linear that EBV DNA was detected in four samples that had re-
R) of arranged IgH genes and in seven samples with germline IgH
e viral genes. EBV DNA was not detected by Southern hybridisa-
trmini tion in a further five samples with rearrangement IgH genes
ity of or in the remaining 19 samples which had germline IgH eny of
gns ich an genes.
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ormed
end (Katz et al., 1989). We have analysed 35 cases of HD for the presence of EBV
will result in a ladder of and HHV-6 DNA sequences and have correlated the results
en in the EBV positive with the age and subtype of the cases, the presence of Ig or
TCRP gene rearrangements and the numbers of HRS cells in
the biopsies. We detected EBV DNA in 11/35 non-selected
cases of HD occurring in the UK. This substantiates previous
studies from laboratories in the USA, Germany and Italy
showing the presence of EBV in biopsies from 17-41% of
patients with HD (Weiss et al., 1987, 1989; Anagnostopoulos
et al., 1989; Boiocchi et al., 1989; Staal et al., 1989; Uccini et
al., 1989). The similarity of the findings from a number of
groups indicates that EBV DNA is consistently found in a
proportion of cases of HD.
In all of the EBV-positive cases that we analysed, using a
4 probe for the viral terminal repeats, the results were consis-
tent with the presence of a clonally expanded population of
EBV-infected cells. In previous studies most of the EBV
<35 35-49 >49 genomes detected in HD biopsies have also been found to be
Age (years) clonal and in a small number of cases EBV DNA has been
EBV positive HD cases. localised to the HRS cells by in situ hybridisation (Anagnos-
are not included in the topoulus et al., 1989; Boiocchi et al., 1989; Uccini et al.,
ir classification (see text). 1989; Weiss et al., 1989). The detection of clonally expanded
e HD cases. EBV-positive cells in these biopsies and the demonstration of
EBV DNA in HRS cells is strongly supportive of a role for
EBV in the pathogenesis of the virus-positive cases.
The significance of these observations has been obscured
by the lack of a reported association between EBV-positivity
and any particular subtype or age group. This is the first
--249 bp study to report a statistically significant association between
the presence of EBV genomes and a subset of HD patients.
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I CD m_ age of cases showed that EBV was more frequently found in
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and that this trend was statistically significant. The pre-
liminary observation that the only two cases aged < 15 years
-.-300bp in our series were both EBV-positive is of interest. Although
the number of cases is small this finding suggests that further
analysis of HD patients in this age bracket for the presence
n the EBV positive HD of EBV genomes is warranted. The majority of other studies
BV type A infected cell have not reported the ages of the cases analysed. Boiocchi et
type B infected cell line al. (1989) and Libetta et al. (1990) did not detect significantly
increased numbers of EBV positive cases in older persons
with HD. However the former study involved only 17 cases
and the criteria for case selection was not given. In the latter
d IgH genes (data not study viral restriction fragments of unusual size were detected
d rearranged IgL genes. in over half of their EBV positive cases. This raises the
ients of the TCRP gene possibility of technical artifact which may in part have
sands was used to esti- resulted from the analysis of formalin-fixed, paraffin-
clonal rearrangements. embedded material.
gene rearrangement the Analysis of the data according to subtype revealed a lower
iggested that the clonal frequency of EBV-positive cases amongst the nodular scleros-
/o ofcells in the sample. ing subtype of HD compared to other subtypes, though this
fical sections from these difference did not achieve statistical significance. Boiocchi et
more than 8% of the al. (1989) reported similar findings and Weiss et al. (1987)
to contain less than 3% and Staal et al. (1989) found a higher proportion of EBV-
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positive cases in MCHD than in NSHD, but again the
differences were not statistically significant.
The epidemiological evidence suggesting that HD may
have an infectious aetiology has been based largely on studies
of HD in the younger peak incidence age group (Gutensohn
& Cole, 1980). NSHD is the predominant subtype amongst
young adults and Alexander et al. (1989) have reported
evidence ofclustering of both NSHD and ofcases aged <35
years.
The age and subtype distribution of our EBV-positive
cases do not therefore support a role for this virus as a
candidate transmissible agent responsible for HD in young
adults. The data suggest that EBV may be involved in the
pathogenesis of HD in older persons. The results are in
keeping with the hypothesis put forward by MacMahon
(1966) which suggests that HD is a grouping of at least three
entities, which probably have distinct aetiologies and can be
distinguished on the basis of age.
In the older cases reactivation of EBV seems more likely
than de novo infection. This may be a result of an age related
decline in T-cell immunity (Weksler, 1983). However it is
unlikely that we are simply detecting a proliferation of EBV-
infected B-cells secondary to an immune deficit associated
with age or with the development of lymphoma. Substantial
clonal populations of EBV genomes such as those detected in
HD biopsies were not detected in NHL samples from old
persons. In addition EBV DNA has been detected in HRS
cells by in situ hybridisation (Anagnostopoulos et al., 1989;
Uccini et al., 1989; Weiss et al., 1989) and as discussed
below, HRS cells do not consistently show features
associated with mature B-cells, such as Ig gene rearrange-
ments.
Most cases in which we detected Ig gene rearrangement
had >8% HRS cells. We also found a correlation between
the number of HRS cells, which were estimated to be present
in the biopsies, and the density of the rearranged bands
detected by Southern blotting. These data provide some
support for the argument that the rearrangements are present
in HRS cells. Ig gene rearrangements were not detected in all
cases containing high numbers of HRS cells indicating that in
some cases the HRS cells have germline Ig genes.
There was no clear evidence for an association between the
detection of EBV DNA and detection of Ig gene rearrange-
ment in the HD samples. The probes used in gene rearrange-
ment analysis are able to detect a clonal gene rearrangement
in approximately 2% of a cell population when 10 yg of are
analysed (data not shown). The EBV BamHl-W probe, by
virtue ofcontaining a reiterated sequence, allows detection of
an EBV genome present in <0.45% of the cells (unpublish-
ed results). The lesser sensitivity of the Ig gene probe could
explain our failure to detect Ig gene rearrangement in EBV-
positive cases with <3% HRS cells. However in cases 24
and 25, which were EBV-positive, the population of HRS
cells was estimated to be 3-8% and greater than 8% respec-
tively, but Ig gene rearrangement was not detected. This
raises the possibility that EBV is infecting a cell type other
than a mature B-cell. Similar findings have been reported by
Weiss et al. (1987) and Herbst et al. (1989). EBV has been
shown to infect and immortalise lymphocytes at varying
stages of maturity (Gregory et al., 1987). Thus in our EBV-
positive cases with germline Ig and TCR genes the virus may
have infected a cell at an early stage in differentiation, prior
to rearrangement of Ig or TCR genes.
Anagnostopoulos et al. (1989) found that EBV-positive
cases appeared to have an increased frequency ofTCRP gene
rearrangement. We did not detect any TCRP gene rearrange-
ments in our series of HD cases, consistent with a number of
other reports (Sundeen et al., 1987; Raghavachar et al., 1988;
O'Connor et al., 1987). The reasons for this discrepancy are
obscure.
EBV type A has been considered the prevalent strain in
western countries, while EBV type B has been found mainly
in central Africa and New Guinea where Burkitt's lymphoma
(BL) in endemic (Zimber et al., 1986; Young et al., 1987).
Recently however, Sixbey et al. (1989) demonstrated that
EBV type B was also widespread in a healthy population in
the USA, and appeared to be more frequently isolated from
immunosuppressed individuals. Despite the immunosuppres-
sion associated with HD we detected only type A virus in
biopsy material.
This study confirms that clonal EBV genomes are present
in a proportion of cases of HD and further shows that older
cases are most likely to be EBV-positive. Other aetiological
agents may be operating in HD occurring in younger per-
sons. Serological studies have implicated HHV-6 as a candi-
date virus (Clark et al., 1990), however we did not detect
HHV-6 DNA in any of 47 cases of HD. Our results do not
support a direct role for HHV-6 in the pathogenesis of HD.
The data provide support for the hypothesis that HD is an
heterogeneous group of conditions with distinct aetiologies.
Further studies are required to determine whether the classi-
fication of HD cases according to their EBV status is useful
in the clinical management of HD patients.
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